Home Nanjing WisMed Technology Co., Ltd. Announces Completion of Share Reduction Plan by Shareholders Holding More Than 5% and Their Concert Parties

Nanjing WisMed Technology Co., Ltd. Announces Completion of Share Reduction Plan by Shareholders Holding More Than 5% and Their Concert Parties

Feb 12, 2022 00:59 CST Updated 00:59
VISHEE

Developer, Manufacturer, and Distributor of Rehabilitation Medical Devices

Stock Code: 688580 Stock Abbreviation:VISHEEAnnouncement No.: 2022-002

The board of directors, all directors, and relevant shareholders of this company guarantee that there are no false records, misleading statements, or significant omissions in the content of this announcement, and they assume legal responsibility for its truthfulness, accuracy, and completeness in accordance with the law.

Important Content Tips:

● Basic Situation of Major Shareholders and Directors' Shareholdings

Before the implementation of this reduction plan, Nanjing Vishee Medical Technology Co., Ltd. (hereinafter referred to as "the Company") shareholder Shenzhen Yanghe Bio-Medical Industry Investment Co., Ltd. (hereinafter referred to as "Yanghe Investment") held 3,509,488 shares of the Company, accounting for 5.13% of the total share capital; Lian Qingming held 451,993 shares of the Company, accounting for 0.66% of the total share capital; Su Cailong held 444,896 shares of the Company, accounting for 0.65% of the total share capital; Li Xiaoming held 172,990 shares of the Company, accounting for 0.25% of the total share capital; Shi Zhuangping held 148,151 shares of the Company, accounting for 0.22% of the total share capital; Tan Fei held 128,634 shares of the Company, accounting for 0.19% of the total share capital; Yang Chongxiang held 118,875 shares of the Company, accounting for 0.17% of the total share capital; Zhou Dongyao held 49,236 shares of the Company, accounting for 0.07% of the total share capital; Zheng Guihua held 49,236 shares of the Company, accounting for 0.07% of the total share capital. The above shareholders are acting in concert and collectively hold 5,073,499 shares of the Company, accounting for 7.42% of the total share capital. The above shares were sourced from pre-IPO shares and had been unrestricted and listed for trading on July 21, 2021.

● Implementation Results of the Reduction Plan

The company recently received a letter from shareholder Yanghe Investment and its concert parties, Lian Qingming, Su Cailong, Li Xiaoming, Shi Zhuangping, Tan Fei, Yang Chongxiang, Zhou Dongyao, and Zheng Guihua, titled "Notice of Completion of the Reduction of VISHEE Shares." The time period for this reduction has expired. As of the date of this announcement, Yanghe Investment and its concert parties have cumulatively reduced their shares in the company by 588,118 through centralized bidding, accounting for 0.86% of the company's total share capital. Among them, Yanghe Investment reduced its shares by 503,802, accounting for 0.74% of the company's total share capital; Lian Qingming reduced his shares by 60,000, accounting for 0.09%; Su Cailong reduced 0 shares, accounting for 0%; Li Xiaoming reduced 0 shares, accounting for 0%; Shi Zhuangping reduced his shares by 11,000, accounting for 0.016%; Tan Fei reduced 0 shares, accounting for 0%; Yang Chongxiang reduced his shares by 13,316, accounting for 0.02%; Zhou Dongyao reduced 0 shares, accounting for 0%; Zheng Guihua reduced 0 shares, accounting for 0%.

1. Basic Information of the Reducing Entity Before Reduction

The above-mentioned entities reducing their holdings have concerted actors:

Note: The above shareholders are acting in concert, collectively holding 5,073,499 shares of the company, accounting for an actual proportion of 7.42% of the total share capital of 68,346,667 shares. Any discrepancies in the totals and the sum of individual figures are due to rounding.

II. Implementation Results of the Reduction Plan

(1) Major shareholders and directors, supervisors, and senior management disclose the implementation results of their reduction plans due to the following matters:

The disclosed reduction time period has expired.

(II) Is the actual reduction situation consistent with the previously disclosed reduction plan and commitment? √ Yes □ No

(III) Upon the expiration of the reduction time period, was the reduction not implemented? □ Not Implemented √ Implemented

(IV) Whether the actual reduction has not reached the minimum reduction quantity (proportion) of the reduction plan □Not reached √Reached

(V) Whether to terminate the reduction plan in advance □ Yes √ No

Hereby announced.

Board of Directors of Nanjing Vishee Medical Technology Co., Ltd.

February 12, 2022